Genetic Technology Alert. Targeting Glucagon Pathway for Treating Diabetes; Improving Stem Cells Differentiation Activity into Bardiomyocytes by Avoiding Genomic Alteration
This issue profiles targeting glucagon pathway for treating diabetes, improving stem cells differentiation activity into bardiomyocytes by avoiding genomic alteration, and monitoring progression of for treatment of complex viral infections. Strategic partnership details and some important patents have also been included.
Click headings to expand and collapse
Published: 27 Apr 2012
Tools
Features of this research
Help Desk
For more information and general enquiries, contact Frost & Sullivan near you.
Select a location near you..